Research institute
It can be a bit difficult to predict exactly what the big stories out of the JP Morgan Healthcare Conference are going to be. There’s no telling if some surprise deal will take the air out of the room, but here’s a look at some of the top presentations.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations
$4.5 million awarded to six outstanding early career scientists to support innovation in cancer research
Testicular cancer can be prevented from coming back using half the amount of chemotherapy that is currently used, a new clinical trial has shown.
Researchers recently identified molecules that can inhibit DNA methylation and kill even the most resistant of the malaria parasites, Plasmodium falciparum.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Instead of injecting the vaccine into the muscle or skin, researchers injected BCG directly into the bloodstream. The results were dramatically improved effectiveness.
A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types.
At the Drug Development Unit at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust in London, the first patient in Phoenix’s first in human “ACTivate Trial” has received ACT® in combination with chemotherapy for treatment of hepatic metastases associated with colorectal and pancreatic cancer.
PRESS RELEASES